1例多重病原感染支气管肺炎患儿的药学监护OA

Objective To investigate the pharmaceutical care provided by clinical pharmacists for a child with bronchopneumonia caused by multiple pathogens.Methods Clinical pharmacists delivered whole-process pharmaceutical care for a child with bronchopneumonia attributed to multiple pathogens,including drug-resistant bacteria.Based on clinical evidence,literature analysis,and in conjunction with etiological findings,precise recommendations regarding the selection and duration of antimicrobial therapy were proposed to the medical team,aiming to ensure the safety,efficacy,and cost-effectiveness of medication.Results After the physician adopted the recommendation to add cefotiam,the child's condition improved significantly.The pharmacist prudently evaluated the rationality of initiating fluconazole solely based on next-generation sequencing results,but this recommendation was not adopted by the physician.Conclusion The clinical pharmacist promptly identified and bridged a treatment gap in the child's antibiotic therapy,and considering the methodological limitations of next-generation sequencing,recommended dynamic monitoring instead of immediate antifungal therapy,thereby demonstrating the dual professional value of maintaining the continuity of the anti-infective regimen while avoiding overtreatment.